KT430

N/A

Report date: 2024/07/26 15:57:34

Base Information

Drug NameKT430
Drug Alias NameKT430KT-430
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsMyotubularin
Therapy Area/IndicationsMyopathies, Structural, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKate Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKate Therapeutics IncAstellas Pharma Inc
Inactive CompaniesN/A
Active IndicationsMyopathies, Structural, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A